MediPal Holdings Corporation
MediPal Holdings Corporation (MAHLY) Revenue
Annual & quarterly revenue history · segment & region breakdown
MAHLY · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsMediPal Holdings Corporation trailing twelve-month (TTM) revenue is $3869B, an increase of 10.25% year-over-year from $4048B in FY2026.
Revenue trend
2026 – 2007 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2026-03-31 | $4048B | +$376.24B | +10.25% |
| 2025-03-31 | $3671B | +$112.60B | +3.16% |
| 2024-03-31 | $3559B | +$198.72B | +5.91% |
| 2023-03-31 | $3360B | +$69.09B | +2.10% |
| 2022-03-31 | $3291B | +$79.75B | +2.48% |
| 2021-03-31 | $3211B | -$41.95B | -1.29% |
| 2020-03-31 | $3253B | +$71.19B | +2.24% |
| 2019-03-31 | $3182B | +$35.59B | +1.13% |
| 2018-03-31 | $3146B | +$82.30B | +2.69% |
| 2017-03-31 | $3064B | +$35.85B | +1.18% |
Compare revenue vs peers
Medical - DistributionCompare MAHLY revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income MediPal Holdings Corporation receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
MediPal Holdings Corporation reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in JPY.
Data sourced from MediPal Holdings Corporation's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
MAHLY revenue · 4 questionsMAHLY's trailing twelve-month (TTM) revenue is $3869B. That is an increase of 10.25% year-over-year from $4048B in FY2026.
▸ Source: FMP · MediPal Holdings Corporation SEC filings · GAAP · MediPal Holdings Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026